LongNUVLJun 2026
Nuvalent Inc.
GSK agreed to acquire Nuvalent for $124.00 per share in cash. The transaction values the oncology company at approximately $9 billion. The event-driven return depends on…
NUVL
Which hedge funds are long NUVL?
1 published idea on Nuvalent Inc. across 1 fund — 1 long and 0 short.
Nuvalent hedge fund investment theses
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Nuvalent: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.